Fisher & Paykel Healthcare Corporation Limited (FPH.NZ) Stock Analysis & Winston Score
Fisher & Paykel Healthcare is a New Zealand company that makes medical devices used to help people breathe. Its main products are humidifiers, breathing circuits, and masks used in hospitals and at home — especially for patients with respiratory problems or sleep apnea. The company is one of the world's leading makers of respiratory humidification systems, and its products are used in intensive care units and sleep clinics across the globe. The company sells its hardware and the consumable parts that go with it — like tubes and masks that need regular replacement — which creates a steady, recurring stream of revenue. Fisher & Paykel operates in over 120 countries, with major markets in the US, Europe, and Asia-Pacific, and generates roughly NZD 2 billion in annual revenue. Its strong gross margins reflect a durable competitive position built on proprietary technology and deep hospital relationships. The key growth driver is rising global demand for respiratory care, though currency fluctuations and competition from larger medical device companies remain ongoing risks.
Winston Score: 66/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Strong (23/30)
- Growth: Strong (15/20)
- Cash Flow: Exceptional (10/10)
- Stability: Exceptional (10/10)
- Valuation: Good (5/10)
- Ownership: Weak (2/15)
Key Facts
Price: 42.24 NZD
Market Cap: 24.8B NZD
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: New Zealand Exchange


